JPRN-UMIN000044463已完成未知
A survey of treatment goals and mutual understanding between patients and physicians in terms of the treatment of rheumatoid arthritis - A survey of treatment goals and mutual understanding between patients and physicians in terms of the treatment of rheumatoid arthritis
Others Eisai Co., Ltd.0 个研究点目标入组 500 人开始时间: 2021年6月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 99years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A) Patients survey Exclude patients with any one following criteria: (i) Patients who work for any of the following organizations - market research companies - media companies - advertising companies - hospitals or clinics - pharmaceutical companies - pharmaceutical wholesalers (ii) Patients with any one following criteria - without history of medical treatment for RA - with history of medical treatment for RA which is withdrawn - with history of medical treatment for RA which is determined B) Physicians survey Exclude physicians without any one inclusion criteria.
研究者
相似试验
撤回
不适用
Shared goal-setting in medical decision-making: the case of lower-limb amputation in Critical Limb Ischemia.Patienten met Kritieke Ischemie (Critical Limb Ischemia)Severe peripheral arterial diseasesevere blockage of the arteries in the lower legs10047079NL-OMON42219Gezondheids, Medische en Neuropsychologie40
暂停
不适用
Web-based Intervention for Employees with DepressioWork productivity (work absenteeism and presenteeism)Mental Health - DepressionDepressionACTRN12612000035820Dr Leanne Casey40
进行中（未招募）
不适用
Investigation of clinical endpoints for treatment-induced gastroesophageal reflux disease (GERD) symptom changes - COMPETITIOgastroesophageal reflux diseaseMedDRA version: 8.1Level: LLTClassification code 10017885Term: Gastrooesophageal reflux diseaseEUCTR2006-000926-30-DEALTANA Pharma AG660
进行中（未招募）
不适用
Investigation of clinical endpoints for treatment-induced gastroesophageal reflux disease (GERD) symptom changes - COMPETITIOgastroesophageal reflux diseaseMedDRA version: 8.1Level: lltClassification code 10017885EUCTR2006-000926-30-HUALTANA Pharma AG660
进行中（未招募）
不适用
Investigation of clinical endpoints for treatment-induced gastroesophageal reflux disease (GERD) symptom changes - COMPETITIOEUCTR2006-000926-30-ATALTANA Pharma AG660